Magnetic
Resonance -
Technology
Information
Portal |
Welcome to MRI Technology• |
|
|
| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | 'Gastrointestinal Paramagnetic Contrast Agents' | |
Result : Searchterm 'Gastrointestinal Paramagnetic Contrast Agents' found in 1 term [] and 4 definitions [], (+ 8 Boolean[] results
| previous 11 - 13 (of 13) Result Pages : [1] [2 3] | | | | | | |
| |
|
Ferristene is a super paramagnetic agent that has been used as a magnetic iron particle solution for gastrointestinal use as a negative contrast agent with 23.4 Fe/200ml required concentration.
See also Abdoscan®, Oral Contrast Agents.
| | | | | |
| | | | | |
| |
|
GastroMARK® belongs to the negative oral contrast agents (same as Lumirem®, another brand name for ferumoxsil). GastroMARK® is used to distinguish the loops of the bowel from other abdominal structures and physiology. When GastroMARK® is ingested, it flows through and darkens the stomach and the small intestine in 30 to 45 minutes. By more clearly identifying the intestinal loops, GastroMARK® improves visualization of adjacent abdominal tissues such as the pancreas.
Drug Information and Specification
PHARMACOKINETIC
Gastrointestinal
OSMOLALITY
250 mosm/kgH2O
CONCENTRATION
52.5mg Fe/300mL
PREPARATION
Finished product
DEVELOPMENT STAGE
For sale
PRESENTATION
Bottles containing 300 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT STAGE
DISTRIBUTOR
USA
GastroMARK®
For sale
| | | | • View the DATABASE results for 'GastroMARK®' (6).
| | | | Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
This super paramagnetic oral contrast agent consists of large iron oxide particles, coated with insoluble material. Abdoscan® particles have a mean diameter no less than 300 nm. Gastrointestinal superparamagnetic contrast agents are used for negative bowel enhancement.
Abdoscan® was approved in Europe but was taken off the market in 2000, and all sales stopped by the end of 2002.
Drug Information and Specification
T2*, predominantly negative enhancement
PHARMACOKINETIC
Gastrointestinal
CONCENTRATION
23.4 Fe/200ml
DEVELOPMENT STAGE
Not FDA approved
PRESENTATION
Bags with powder
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
| | | | • View the DATABASE results for 'Abdoscan®' (2).
| | | | |
| | | | |
| |
| | | |
|
| |
| Look Ups |
| |
|
MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies. | | [last update: 2024-02-26 03:41:00] |
|
|